Back to the full story3 sources · FDA Clears Roche And Eli Lilly’s Alzheimer’s Blood Test◆ Analytics
FDA Clears Roche And Eli Lilly’s Alzheimer’s Blood Test
Deterministic text analytics computed across all 3 sources. Frequency, entity overlap, and claim overlap — computed counts only. Nothing is rated true or false.
01
Frequency Analytics
The most common words and exact phrases across every report in this cluster. Computed counts only.
Top words
testalzheimerrochelillybloodclearanceminimallydevelopedeuropeanapproval
Top phrases
alzheimer blood testalzheimer bloodblood testeli lillyeli lilly alzheimer blood testlilly alzheimer blood testeli lilly alzheimer bloodlilly alzheimer bloodeli lilly alzheimerroche and eli lilly
02
Entity Overlap
Names detected in the report text: which appear across multiple sources, and which only one source mentions.
Across multiple sources
None mentioned by more than one source.
Unique to one source
- Roche · The Straits Times
- Eli Lilly’s Alzheimer’s · The Straits Times
- US FDA · The Straits Times
- Alzheimer’s · Forbes
03
Claim Overlap
Near-identical sentences found in two or more reports, versus sentences that appear in only one. Text match only — nothing is rated true or false.
Repeated across sources
No sentence appeared in more than one source.
Appears once
- "The nod follows European approval for the Elecsys pTau217 test in May." · The Straits Times
- "The new test promises to be “minimally invasive” and can help doctors identify symptoms of Alzheimer’s disease earlier." · Forbes